| Literature DB >> 35735662 |
Jamille Oliveira Costa1, Felipe J Aidar2,3,4, Juliana Santos Barbosa1, Luciana Vieira Sousa Alves1, Victor Batista Oliveira1, Larissa Marina Santana Mendonça de Oliveira1, Raysa Manuelle Santos Rocha1, Diva Aliete Dos Santos Vieira5, Ingrid Maria Novais Barros de Carvalho Costa6, Márcia Ferreira Cândido de Souza7, Joselina Luzia Menezes Oliveira1,8,9,10, Leonardo Baumworcel10, Eduardo Borba Neves11, Alfonso López Díaz-de-Durana12, Marcos Antonio Almeida-Santos10,13, Antônio Carlos Sobral Sousa1,8,9,10.
Abstract
BACKGROUND: "The effective treatment of Heart Failure (HF) involves care with food intake. Recently, the Ministry of Health created the Brazilian Cardioprotective Diet and its dietary index, BALANCE, which assesses adherence to the standard's recommendations".Entities:
Keywords: cardiac insufficiency; cardiovascular diseases; dietary patterns; food consumption; quality of life
Year: 2022 PMID: 35735662 PMCID: PMC9221597 DOI: 10.3390/clinpract12030043
Source DB: PubMed Journal: Clin Pract ISSN: 2039-7275
Figure 1Food groups according to the BALANCE dietary index classification.
Total and group scores for the BALANCE dietary index according to sociodemographic, clinical, lifestyle and nutritional characteristics of patients hospitalized with CHF in Aracaju, SE, in 2021.
| Variables | Adherence | Green Group | Yellow Group | Blue Group | Red Group | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| B * | IC95 | B * | IC95 | B * | IC95 | IRR ** | IC95 | B * | IC95 | |
|
| 0.00 | −0.00; 0.01 | 0.00 | −0.00; 0.00 | −0.00 | −0.03; 0.02 | 1.00 | 0.99; 1.01 | 0.00 | −0.00; 0.02 |
|
| ||||||||||
| Male ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Female ( | 0.09 | −0.02; 0.22 | 0.06 | −0.02; 0.15 | −0.00 | −0.83; 0.81 | 1.27 | 0.87; 1.01 | −0.02 | −0.36; 0.31 |
|
| ||||||||||
| Not black ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Black ( | −0.03 | −0.16; 0.10 | 0.01 | −0.08; 0.11 | −0.15 | −1.13; 0.82 | 1.05 | 0.72; 1.52 | −0.06 | −0.45; 0.32 |
|
| ||||||||||
| Single ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| With partner ( | 0.00 | −0.11; 0.12 | 0.09 | 0.00; 0.17 | −0.58 | −1.42; 0.25 | 0.91 | 0.65; 1.25 | 0.09 | −0.24; 0.43 |
|
| ||||||||||
| <1 MW ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| ≥1 MW ( | −0.06 | −0.21; 0,09 | −0.07 | −0.19; 0.04 | −0.09 | −1.20; 1.02 | 0.98 | 0.67; 1.42 | −0.06 | −0.45; 0.32 |
|
| ||||||||||
| Private ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Public ( | −0.05 | −0.22; 0.10 | 0.01 | −0.10; 0.14 | −0.60 | −1.70; 0.49 | 0.90 | 0.56; 1.45 | −0.35 | −0.87; 0.15 |
|
| ||||||||||
| No ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| yes ( | −0.03 | −0.16; 0.10 | −0.08 | −0.18; 0.01 | 0.82 | −0.08; 1.73 | 1.33 | 0.95; 1.86 | −0.04 | −0.42; 0.32 |
|
| ||||||||||
| No ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Yes ( | 0.10 | −0.02; 0.23 | 0.00 | −0.08; 0.10 | −0.35 | −1.20; 0.49 | 1.30 | 0.93; 1.82 | 0.41 | 0.05; 0.77 |
|
| ||||||||||
| Not overweight ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Overweight ( | −0.02 | −0.14; 0.10 | 0.01 | −0.07; 0.11 | 0.14 | −0.68; 0.98 | 0.54 | 0.38; 0.78 | 0.09 | −0.26; 0.44 |
|
| ||||||||||
| Absent/Mild/Moderate ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| High Level ( | 0.02 | −0.14; 0.18 | 0.04 | −0.07; 0.16 | 0.23 | −1.05; 1.52 | 1.21 | 0.81; 1.82 | −0.22 | −0.71; 0.27 |
|
| ||||||||||
| No ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Yes ( | −0.04 | −0.21; 0.13 | 0.05 | −0.07; 0.17 | −0.47 | −1.75; 0.80 | 0.58 | 0.29; 1.16 | −0.46 | −0.99; 0.07 |
|
| ||||||||||
| No ( | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Yes ( | 0.05 | −0.20; 0.32 | 0.02 | −0.16; 0.21 | 0.33 | −1.44; 2.11 | 1.68 | 0.77; 3.65 | −0.17 | −0.97; 0.61 |
IC95—confidence interval; B *—coeficients β; IRR **—incidence rate ratio; MW—minimum wage; HF—heart failure; BMI—body mass index.
Logistic and linear regressions and their respective confidence intervals between the total BALANCE dietary index and by food group, and the clinical variables of patients hospitalized with CHF in Aracaju, SE, 2021.
| Logistic Regression | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adherence | Green Group | Yellow Group | Blue Group | Red Group | ||||||
| OR | CI95 | OR | CI95 | OR | CI95 | OR | CI95 | OR | CI95 | |
|
| ||||||||||
| 1 and 2 | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| 3 and 4 | 0.98 | 0.89; 1.08 | 1.14 | 0.93; 1.40 | 0.99 | 0.85; 1.15 | 1.01 | 0.84; 1.21 | 0.87 | 0.73; 1.02 |
|
| ||||||||||
| Changed | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Preserved | 1.05 | 0.98; 1.13 | 0.91 | 0.78; 1.05 | 1.09 | 0.98; 1.22 | 1.00 | 0.89; 1.13 | 1.11 | 0.98; 1.26 |
|
| ||||||||||
| Uneventful | Ref. | Ref. | Ref. | Ref. | Ref. | |||||
| Intercurring | 0.98 | 0.92; 1.04 | 0.95 | 0.83; 1.09 | 0.95 | 0.86; –1.05 | 1.05 | 0.94; 1.18 | 0.98 | 0.88; 1.10 |
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
| |
|
| −0.01 | −0.06; 0.03 | 0.05 | −0.05; 0.17 | −0.09 | −0.17; −0.01 | 0.00 | −0.08; 0.96 | 0.03 | −0.06; 0.12 |
|
| −0.00 | −0.03; 0.02 | 0.01 | −0.06; 0.08 | −0.00 | −0.05; 0.05 | 0.01 | −0.04; 0.07 | −0.03 | −0.10; 0.02 |
NYHA—New York Heart Association; EF—ejection fraction; LVESD—left ventricular end-systolic diameter; LVEDD—left ventricular end-diastolic diameter. * Adjustment variables: age, sex, alcohol, race, smoking, IPAQ, BMI, hypertension and diabetes.